Joint Computational-Experimental Discovery of Novel Dopamine D2 Receptor Partial Agonists and Biased Agonists toward Better Schizophrenia/Parkinson's Medications

Project Details

StatusActive
Effective start/end date2/15/212/28/22

Funding

  • New Jersey Health Foundation, Inc. (NJHF): $35,000.00